A rational basis for selecting drugs for older patients with epilepsy

Geriatrics

Volumn 59, Issue 12, 2004, Pages

  Leppik, Ilo E ^a,b,c   Bergey, Gregory K ^a,d   Ramsay, R Eugene ^a,e   Rowan, A J ^f   Gidal, Barry E ^g   Birnbaum, Angela K ^b   Elliott, Mary Beth ^g  

^a Department of Pharmacy ^*

^b UNIVERSITY OF MINNESOTA   (United States)

^c MINCEP Epilepsy Care   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MIAMI   (United States)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Antiepileptic drugs (AEDs); Epilepsy; Geriatrics; Seizures elderly

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

AGRANULOCYTOSIS; APLASTIC ANEMIA; ATAXIA; BEHAVIOR DISORDER; BRAIN DISEASE; CARDIOTOXICITY; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DIZZINESS; DRUG ABSORPTION; DRUG METABOLISM; DRUG PREFERENCE; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EDEMA; EPILEPSY; FATIGUE; GLAUCOMA; HAIR LOSS; HUMAN; HYPONATREMIA; INSOMNIA; INTESTINE MOTILITY; KIDNEY FUNCTION; LIVER METABOLISM; LONG TERM CARE; MYOCLONUS; NAUSEA; NEPHROLITHIASIS; NURSING HOME; OSTEOLYSIS; OSTEOPOROSIS; PARESTHESIA; RASH; REVIEW; SEDATION; SEIZURE; SEXUAL DYSFUNCTION; SOMNOLENCE; STEVENS JOHNSON SYNDROME; STOMACH EMPTYING; STOMACH PH; TOXIC EPIDERMAL NECROLYSIS; TREMOR; VOMITING; WEIGHT GAIN; AGED; DRUG INTERACTION; GERIATRIC ASSESSMENT;

AGED; ANTICONVULSANTS; DRUG INTERACTIONS; EPILEPSY; GERIATRIC ASSESSMENT; HUMANS;

EID: 13844281709     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Cloyd JC, Lackner TE, Leppik IE. Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokinetics. Arch Fam Med 1994; 3(7):589-98.
2. Lackner TE, Cloyd JC, Thomas LW, Leppik IE. Antiepileptic drug use in nursing home residents: Effect of age, gender, and comedication on patterns of use. Epilepsia 1998; 39(10):1083-7.
3. Garrard J, Harms S, Hardie N, et al. Antiepileptic drug use in nursing home admissions. Ann Nuerol 2003; 54(1):75-85.
4. Birnbaum A, Hardie NA, Leppik IE, et al. Variability of total phenytoin serum concentrations within elderly nursing home residents. Neurology 2003; 60(4):555-9.
5. Pryor FM, Ramsay RE, Rowan AJ, et al. DVA-CSP #428. Study Group. Epilepsy in Older Adults Update. Update from VA Cooperative Study #428. Epilepsia 2002; 43(Suppl 7):165-6.
6. Morrell MJ, Leppik I, French J, Ferrendelli J, Han J, Magnus L. The KEEPER trial: Levetiracetam adjunctive treatment of partial-onset seizures in an open-label community-based study. Epilepsy Res 2003; 54(2-3):153-61.
7. Morrell MJ, McLean MJ, Willmore LJ, et al. Efficacy of gabapentin as adjunctive therapy in a large, multicenter study. The Steps Study Group. Seizure 2000; 9(4):241-8.
8. Hauser WA. Seizure disorders: The changes with age. Epilepsia 1992; 33(Suppl 4):S6-14.
9. Hauser WA, Annegers JF, Kurland LT. Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993; 34(3):453-68.
10. Cloyd JC, Remmel RP. Antiepileptic drug pharmacokinetics and interactions: Impact on the treatment of epilepsy. Pharmacotherapy 2000; 20(8 Pt 2):139S-151S.
11. Firth M, Prather CM. Gastrointestinal motility problems in the elderly patient. Gastroenterology 2002;122(6):1688-700.
12. Brodie MJ, Overstall PW, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999; 37(1):81-7.
13. Welty TE, Gidal BE, Ficker DM, Privitera MD. Levetiracetam: A different approach to the pharmacotherapy of epilepsy. Ann Pharmacother 2002; 36(2):296-304.
14. McLean MJ, Gidal BE. Gabapentin dosing in the treatment of epilepsy. Clin Ther 2003; 25(5):1382-406.
15. Werz MA, Lang P, Rienzo T. Levetiracetam therapy for epilepsy: Use and tolerability in the elderly. Epilepsia 2003;44(suppl 9):280.
16. Hachad H, Ragueneau-Majlessi I, Levy RH. New antiepileptic drugs: Review on drug interactions. Ther Drug Monit 2002; 24(1)91-103.
17. Vestergaard P, Tigaran S, Rejnmark L, Tigaran C, Dam M, Mosekilde L. Fracture risk is increased in epilepsy. Acta Neurol Scand 1999; 99(5):269-75.
18. Mattson RH, Cramer JA, Collins JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. N Engl J Med 1992; 327(11):765-71.
19. Leppik IE, Wolff D. Drug interactions in the elderly with epilepsy. In: Ramsay RE, Rowan AJ. Seizures and epilepsy in the elderly. Boston: Butterworth-Heinemann, 1998: 291-302.
20. Sachdeo RC, Wasserstein A, Mesenbrink PJ, D'Souza J. Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol 2002; 51(5):613-20.
21. Martin R, Meador K, Turrentine L, et al. Comparative cognitive effects of carbamazepine and gabapentin in health senior adults. Epilepsia 2001; 42(6):764-71.
22. Cramer JA, Leppik IE, Rue KD, Edrich P, Kramer G. Tolerability of levetiracetam in elderly patients with CNS disorders. Epilepsy Res 2003; 56(2-3):135-45.